CAD 1.0
(-0.99%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 57.33 Million USD | 6.51% |
2022 | 53.83 Million USD | 192.72% |
2021 | 18.39 Million USD | 145.38% |
2020 | 7.49 Million USD | -32.11% |
2019 | 11.03 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.54 Million USD | -65.41% |
2024 Q2 | 4.07 Million USD | -5.56% |
2023 FY | 57.33 Million USD | 6.51% |
2023 Q2 | 18.11 Million USD | 22.39% |
2023 Q4 | 10.25 Million USD | -0.77% |
2023 Q3 | 10.33 Million USD | -42.96% |
2023 Q1 | 14.79 Million USD | -24.22% |
2022 FY | 53.83 Million USD | 192.72% |
2022 Q4 | 19.52 Million USD | 89.02% |
2022 Q3 | 10.33 Million USD | -23.43% |
2022 Q2 | 13.49 Million USD | 28.99% |
2022 Q1 | 10.46 Million USD | 71.39% |
2021 Q4 | 6.1 Million USD | -17.84% |
2021 Q1 | 2.08 Million USD | 110.53% |
2021 Q3 | 7.42 Million USD | 167.19% |
2021 FY | 18.39 Million USD | 145.38% |
2021 Q2 | 2.77 Million USD | 33.63% |
2020 Q3 | 1.93 Million USD | -14.38% |
2020 Q2 | 2.26 Million USD | -1.57% |
2020 Q1 | 2.3 Million USD | -15.32% |
2020 FY | 7.49 Million USD | -32.11% |
2020 Q4 | 988.19 Thousand USD | -49.06% |
2019 Q3 | 2.69 Million USD | 0.0% |
2019 Q4 | 2.71 Million USD | 0.88% |
2019 FY | 11.03 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -1834.551% |
CanadaBis Capital Inc. | 7.1 Million CAD | -706.82% |
Decibel Cannabis Company Inc. | 40.44 Million CAD | -41.764% |
Delivra Health Brands Inc. | 7.1 Million CAD | -706.571% |
Entourage Health Corp. | 3.7 Million CAD | -1446.488% |
Lifeist Wellness Inc. | 17.59 Million CAD | -225.896% |
Cannara Biotech Inc. | 15.34 Million CAD | -273.717% |
Medicure Inc. | 13.98 Million CAD | -309.887% |
PharmaCielo Ltd. | 8.33 Million CAD | -588.171% |
Rubicon Organics Inc. | 14.22 Million CAD | -303.109% |
BioSyent Inc. | 17.6 Million CAD | -225.636% |
Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -4596.262% |